Copper: Humanity's Ancient Ally Against Growing Antibiotic-Resistant Infections

Researchers at Texas A&M are tapping into the body's own defense mechanisms, specifically the essential trace mineral copper, to combat the rising threat of antibiotic-resistant urinary tract infections (UTIs). Led by Dr. Sarguru Subash, a team at the Texas A&M College of Veterinary Medicine and Biomedical Sciences recently secured a $1.48 million grant from the National Institutes of Health to explore how the body uses copper to kill infection-causing bacteria and crucially, how those bacteria learn to fight back. Their findings could pave the way for completely new types of treatments. The urgency for such innovation is immense, as the world faces a looming public health crisis with common antibiotics losing their power. While new drugs like Blujepa (approved in April 2024 for uncomplicated UTIs) and Utebzi (approved in July 2026 for complicated UTIs) offer some relief, bacteria continue to evolve, making infections increasingly difficult to treat. This research takes on even more significance given recent findings from UCLA in August 2025, which showed that heavy, continuous use of copper antimicrobials can itself drive bacteria to develop copper resistance, sometimes even alongside antibiotic resistance. This highlights the delicate balance needed and the importance of understanding bacterial adaptation. Looking ahead, the Texas A&M team aims to develop 'host-directed' therapies that work with the body's natural defenses, potentially making existing treatments more effective or leading to entirely new ones. While clinically available copper-dependent treatments are still years away, the insights gained from this research could revolutionize our approach to bacterial infections, with implications extending beyond UTIs to other bacterial diseases and even veterinary medicine, offering a glimmer of hope in the fight against superbugs.